
Vericel announces FDA approval, commercial availability of MACI Arthro
Vericel (NASDAQ:VCEL) has introduced that the U.S. FDA has authorised a supplemental Biologics License Application increasing the MACI® label to incorporate arthroscopic supply…

Vericel (NASDAQ:VCEL) has introduced that the U.S. FDA has authorised a supplemental Biologics License Application increasing the MACI® label to incorporate arthroscopic supply…

Vericel (NASDAQ:VCEL) has introduced that the U.S. FDA has authorized a supplemental Biologics License Application increasing the MACI® label to incorporate arthroscopic supply…